Please use this identifier to cite or link to this item: http://hdl.handle.net/11054/2276
Title: Costs associated with invasive Scedosporium and Lomentospora prolificans infections: a case-control study.
Author: Neoh, C.
Chen, S.
Kong, David C. M.
Hamilton, K.
Nguyen, Q.
Spelman, T.
Tew, M.
Harvey, E.
Ho, S.
Saunders, N.
Tennakoon, S.
Crowe, A.
Marriott, D.
Trubiano, J.
Slavin, M.
Issue Date: 2023
Publication Title: Journal of Antimicrobial Chemotherapy
Volume: 79
Issue: 1
Start Page: 46
End Page: 54
Abstract: Background Little is known about the short- and long-term healthcare costs of invasive Scedosporium/Lomentospora prolificans infections, particularly in patient groups without haematological malignancy. This study investigated excess index hospitalization costs and cumulative costs of these infections. The predictors of excess cost and length of stay (LOS) of index hospitalization were determined. These estimates serve as valuable inputs for cost-effectiveness models of novel antifungal agents. Methods A retrospective case-control study was conducted at six Australian hospitals. Cases of proven/probable invasive Scedosporium/L. prolificans infections between 2011 and 2021 (n = 34) were matched with controls (n = 66) by predefined criteria. Cost data were retrieved from activity-based costing systems and analysis was performed from the Australian public hospital perspective. All costs were presented in 2022 Australian dollars (AUD). Median regression analysis was used to adjust excess costs of index hospitalization whereas cumulative costs up to 1.5 years follow-up were estimated using interval-partitioned survival probabilities. Results Invasive Scedosporium/L. prolificans infections were independently associated with an adjusted median excess cost of AUD36 422 (P = 0.003) and LOS of 16.27 days (P < 0.001) during index hospitalization. Inpatient stay was the major cost driver (42.7%), followed by pharmacy cost, of which antifungal agents comprised 23.8% of the total cost. Allogeneic haematopoietic stem cell transplant increased the excess cost (P = 0.013) and prolonged LOS (P < 0.001) whereas inpatient death within ≤28 days reduced both cost (P = 0.001) and LOS (P < 0.001). The median cumulative cost increased substantially to AUD203 292 over 1.5 years in cases with Scedosporium/L. prolificans infections. Conclusions The economic burden associated with invasive Scedosporium/L. prolificans infections is substantial.
URI: http://hdl.handle.net/11054/2276
DOI: https://doi.org/10.1093/jac/dkad345
Internal ID Number: 02398
Health Subject: ANTIFUNGAL AGENTS
FOLLOW-UP
HEALTH CARE COSTS
HEMATOLOGIC NEOPLASMS
INPATIENTS
LENGTH OF STAY
SCEDOSPORIUM
INFECTIONS
ECONOMICS
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT
Type: Journal Article
Article
Appears in Collections:Research Output

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.